183 related articles for article (PubMed ID: 36582458)
1. Proof of Concept of the Radiosensitizing Effect of Gadolinium Oxide Nanoparticles in Cell Spheroids and a Tumor-Implanted Murine Model of Chondrosarcoma.
Aloy MT; Sidi Boumedine J; Deville A; Kryza D; Gauthier A; Brichart-Vernos D; Ollier G; La Padula V; Lux F; Tillement O; Rodriguez-Lafrasse C; Janier M
Int J Nanomedicine; 2022; 17():6655-6673. PubMed ID: 36582458
[TBL] [Abstract][Full Text] [Related]
2. Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model.
Palubeckaitė I; Venneker S; van den Akker BEWM; Briaire-de Bruijn IH; Boveé JVMG
Clin Orthop Relat Res; 2023 Mar; 481(3):608-619. PubMed ID: 36729612
[TBL] [Abstract][Full Text] [Related]
3. Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research?
Ma R; Mandell J; Lu F; Heim T; Schoedel K; Duensing A; Watters RJ; Weiss KR
Clin Orthop Relat Res; 2021 Mar; 479(3):477-490. PubMed ID: 32469486
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization Effect of AGuIX, a Gadolinium-Based Nanoparticle, in Nonsmall Cell Lung Cancer.
Du Y; Sun H; Lux F; Xie Y; Du L; Xu C; Zhang H; He N; Wang J; Liu Y; Leduc G; Doussineau T; Ji K; Wang Q; Lin Z; Wang Y; Liu Q; Tillement O
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56874-56885. PubMed ID: 33326207
[TBL] [Abstract][Full Text] [Related]
5. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation.
Wang K; Michelakos T; Wang B; Shang Z; DeLeo AB; Duan Z; Hornicek FJ; Schwab JH; Wang X
Cancer Lett; 2021 May; 505():37-48. PubMed ID: 33582212
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Radiosensitization by Silver Nanoparticles Functionalized with Polyethylene Glycol and Aptamer As1411 for Glioma Irradiation Therapy.
Zhao J; Liu P; Ma J; Li D; Yang H; Chen W; Jiang Y
Int J Nanomedicine; 2019; 14():9483-9496. PubMed ID: 31819445
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the c-myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses.
Qian J; Zhang Z; Han X; Zhu L; Bian Z; Xie T
Biomed Res Int; 2022; 2022():1948657. PubMed ID: 35141331
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing.
Voissiere A; Jouberton E; Maubert E; Degoul F; Peyrode C; Chezal JM; Miot-Noirault É
PLoS One; 2017; 12(7):e0181340. PubMed ID: 28704566
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization with Gadolinium Chelate-Coated Gold Nanoparticles Prevents Aggressiveness and Invasiveness in Glioblastoma.
Durand M; Chateau A; Jubréaux J; Devy J; Paquot H; Laurent G; Bazzi R; Roux S; Richet N; Reinhard-Ruch A; Chastagner P; Pinel S
Int J Nanomedicine; 2023; 18():243-261. PubMed ID: 36660336
[TBL] [Abstract][Full Text] [Related]
10. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
[TBL] [Abstract][Full Text] [Related]
11. MRI-guided clinical 6-MV radiosensitization of glioma using a unique gadolinium-based nanoparticles injection.
Verry C; Dufort S; Barbier EL; Montigon O; Peoc'h M; Chartier P; Lux F; Balosso J; Tillement O; Sancey L; Le Duc G
Nanomedicine (Lond); 2016 Sep; 11(18):2405-17. PubMed ID: 27529506
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the theranostic properties of gadolinium-based nanoparticles for head and neck cancer.
Quatre R; Jacquet T; Atallah I; Tillement O; Lux F; Coll JL; Dufort S; Righini CA
Head Neck; 2019 Feb; 41(2):403-410. PubMed ID: 30548507
[TBL] [Abstract][Full Text] [Related]
13. In vitro hyperspectral biomarkers of human chondrosarcoma cells in nanoparticle-mediated radiosensitization using carbon ions.
Tudor M; Popescu RC; Negoita RD; Gilbert A; Ilisanu MA; Temelie M; Dinischiotu A; Chevalier F; Mihailescu M; Savu DI
Sci Rep; 2023 Sep; 13(1):14878. PubMed ID: 37689817
[TBL] [Abstract][Full Text] [Related]
14. Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial).
Verry C; Dufort S; Villa J; Gavard M; Iriart C; Grand S; Charles J; Chovelon B; Cracowski JL; Quesada JL; Mendoza C; Sancey L; Lehmann A; Jover F; Giraud JY; Lux F; Crémillieux Y; McMahon S; Pauwels PJ; Cagney D; Berbeco R; Aizer A; Deutsch E; Loeffler M; Le Duc G; Tillement O; Balosso J
Radiother Oncol; 2021 Jul; 160():159-165. PubMed ID: 33961915
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitizing Effect of Dextran-Coated Iron Oxide Nanoparticles on Malignant Glioma Cells.
Tran NH; Ryzhov V; Volnitskiy A; Amerkanov D; Pack F; Golubev AM; Arutyunyan A; Spitsyna A; Burdakov V; Lebedev D; Konevega AL; Shtam T; Marchenko Y
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894830
[TBL] [Abstract][Full Text] [Related]
16. Selection of Effective Therapies Using Three-Dimensional
Palubeckaitė I; Venneker S; Briaire-de Bruijn IH; van den Akker BE; Krol AD; Gelderblom H; Bovée JVMG
Front Mol Biosci; 2020; 7():566291. PubMed ID: 33425984
[No Abstract] [Full Text] [Related]
17. Ultrasmall theranostic gadolinium-based nanoparticles improve high-grade rat glioma survival.
Dufort S; Appelboom G; Verry C; Barbier EL; Lux F; Bräuer-Krisch E; Sancey L; Chang SD; Zhang M; Roux S; Tillement O; Le Duc G
J Clin Neurosci; 2019 Sep; 67():215-219. PubMed ID: 31281087
[TBL] [Abstract][Full Text] [Related]
18. Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma.
Miladi I; Aloy MT; Armandy E; Mowat P; Kryza D; Magné N; Tillement O; Lux F; Billotey C; Janier M; Rodriguez-Lafrasse C
Nanomedicine; 2015 Jan; 11(1):247-57. PubMed ID: 24983891
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept.
Voissiere A; Weber V; Gerard Y; Rédini F; Raes F; Chezal JM; Degoul F; Peyrode C; Miot-Noirault E
Oncotarget; 2017 Nov; 8(56):95824-95840. PubMed ID: 29221170
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.
Thiemann M; Oertel S; Ehemann V; Weichert W; Stenzinger A; Bischof M; Weber KJ; Perez RL; Haberkorn U; Kulozik AE; Debus J; Huber PE; Battmann C
Radiat Oncol; 2012 Mar; 7():52. PubMed ID: 22458853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
